HolderBook

INNOVATE BIOPHARMACEUTICLS I (INNT)

Institutional ownership reported to the SEC as of Q1 2020, across 6 quarters.

20
Reporting holders
$855.7K
Reported value
1.4%
Held as options
+0
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
VANGUARD GROUP INC$363.0K721,0460.00%6qHELD
BlackRock Inc.$178.0K355,1750.00%6q-0.8%-$1.5K
RENAISSANCE TECHNOLOGIES LLC$113.0K225,3990.00%2q+221.5%+$77.9K
GEODE CAPITAL MANAGEMENT, LLC$57.0K113,9680.00%6q-50.0%-$57.0K
CITADEL ADVISORS LLC$37.0K51,0620.00%newNEW
NORTHERN TRUST CORP$21.0K41,2400.00%6qHELD
Summit X, LLC$20.0K34,0000.01%3q+3.0%
Ashfield Capital Partners, LLC$17.0K33,3530.00%newNEW
Heritage Wealth Advisors$15.1K30,0000.00%2qHELD
BREWIN DOLPHIN LTD$12.6K25,0000.00%4qHELD
Raymond James Financial Services Advisors, Inc.$7.0K13,1830.00%2q+27.0%+$1.5K
VICTORY CAPITAL MANAGEMENT INC$6.0K11,3100.00%newNEW
GROUP ONE TRADING, L.P.$2.0K4,8660.00%2qHELD
DEUTSCHE BANK AG\$2.0K3,1730.00%9q-86.1%-$12.3K
BANK OF AMERICA CORP /DE/$1.0K2,8000.00%newNEW
MORGAN STANLEY$1.0K1,0000.00%9qHELD
ROYAL BANK OF CANADA$1.0K2,5000.00%6q+25.0%
Cutler Group LP$1.0K2,8000.00%6qHELD
UBS Group AG$1.0K1,7050.00%2q-83.3%-$5.0K
BNP PARIBAS ARBITRAGE, SA$551100.00%5qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202020$855.7K1,673,6904441.4%
Q4 201920$1.4M2,563,6665750.0%
Q3 201917$2.8M2,629,32021100.0%
Q2 201927$4.1M3,509,2647790.0%
Q1 201937$7.2M3,748,88579100.0%
Q4 201841$7.8M3,364,7533110.8%